Study Results: Bioretec Bioresorbable Elastic Activa IM-Nail

Bioretec has developed and commercialized what the company reports is the world's first bioresorbable elastic intramedullary nail, Activa IM-Nail™, which makes implant removal operations redundant. Activa IM-Nail received approval under the CE Mark in 2020.

Interim results of an international postmarket clinical follow-up study show that...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us